Kathleen Herkenhoff joined Haeggquist & Eck as a partner in June 2017. For the past 24 years, Kathleen has exclusively focused her practice on litigating complex securities class and derivative actions in courts across the country, and she has helped obtain more than $1 billion in settlement recoveries. She will expand her practice to include litigation of claims on behalf of Haeggquist & Eck clients in all of the firm’s dynamic practice areas.
Kathleen started her law career in 1993 at the United States Securities and Exchange Commission’s Pacific Regional Office in Los Angeles, where she investigated and prosecuted complex securities fraud and insider trading actions, including securing a $22 million securities fraud judgment in favor of the SEC. In 1997, she joined Milberg Weiss Bershad Hynes & Lerach LLP (later Coughlin Stoia) in Los Angeles and later moved to the firm’s San Diego office, where she served as a partner from 2002 to 2009. During her 12 years at the firm, she practiced in all areas of securities class and derivative litigation, and settled numerous actions for both monetary recoveries and sweeping corporate governance improvements. A sample of these notable settlements include:
· $618 million in opt-out litigation against AOL Time Warner, Inc.
· $122 million in class action against Mattel, Inc.
· $100 million in class action against Honeywell International, Inc.
· $30+ million in derivative stock option backdating cases
Kathleen was also one of the first attorneys at Coughlin Stoia to handle the litigation of the consolidated securities class action ultimately known as In re HealthSouth Corp. Sec. Litig., which action settled (in stages) after years of litigation for a combined recovery of approximately $671 million.
In 2010, Kathleen joined the Weiser Law Firm, P.C.’s merger & acquisition and derivative practice groups. At Weiser, she played a key role in drafting and obtaining cutting edge corporate governance reforms at SciClone Pharmaceuticals, Inc., based on conduct the plaintiffs alleged violated the Foreign Corrupt Practices Act of 1977. She secured the firm’s position as lead counsel in an action that obtained more than $10 million in consideration and novel governance improvements (In re Velti PLC Securities Litig., Master File No. 3:13-cv 03889-WHO (N.D. Cal. Feb. 3, 2015) and played an instrumental role as co-lead counsel in shareholder derivative litigation which resulted in more than $10 million in financial consideration being secured for Diamond Foods, Inc.’s benefit. Kathleen was also involved in key aspects of the litigation of shareholder derivative litigation against various Allergan, Inc. insiders for the alleged illegal marketing of Botox.
Kathleen holds a B.A. in English Literature from the University of California at Berkeley, where she served as a Philanthropy Chair of Alpha Omicron Pi sorority. She earned her law degree from Pepperdine University School of Law in 1993, where she was on the Dean’s Honor List and received American Jurisprudence Awards in both Constitutional Law and Agency-Partnership.
A native of San Jose, Calif., Kathleen calls San Diego home, but maintains strong ties to the Bay Area community. She has worked in several major cities in California, including San Francisco, San Jose, Sacramento, Los Angeles, and San Diego, and currently resides in Carmel Valley. She has enjoyed a nationwide practice, and her employment positions at entities throughout California have served to strengthen her understanding of the unique and diverse challenges facing clients in their respective communities. Her extensive and longstanding litigation background will be fully dedicated to achieving strong results for Haeggquist & Eck, LLP clients.